Top Markets
Coin of the day
Ocumension Therapeutics Ocumension Therapeutics

Ocumension Therapeutics

1477
Classifica tra le azioni #12973
Based in the People's Republic of China, Ocumension Therapeutics functions as a... Based in the People's Republic of China, Ocumension Therapeutics functions as a dedicated ophthalmic pharmaceutical platform. This company, along with its subsidiaries, is committed to the research, progression, and market introduction of therapeutic solutions for individuals with various eye conditions. Its extensive product offerings target treatments for disorders such as blepharitis, infectious and allergic conjunctivitis, dry eye syndrome, cataracts, glaucoma, ocular hypertension, post-surgical inflammation, uveitis, retinitis pigmentosa, age-related macular degeneration, corneal graft rejection, myopia, and optic neuritis. By December 31, 2021, Ocumension Therapeutics boasted a pipeline of 20 drug assets. The company, founded in 2017, maintains its headquarters in Suzhou, China.
Prezzo delle azioni
$0.66137861
Capitalizzazione di mercato
$531.70M
Variazione (1 giorno)
-2.45%
Variazione (1 anno)
-42.12%
Paese
CN
Scambia Ocumension Therapeutics (1477)

Categoria

Storico del prezzo dell'azione per Ocumension Therapeutics (1477)
Prezzo di chiusura più alto: $0.68 il 2026-08-01

Prezzo di chiusura più basso: $4.11 il 2020-07-01
Storico del prezzo dell'azione di Ocumension Therapeutics dal 2020 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -10.84%
2025 66.97%
2024 -28.81%
2023 -25.43%
2022 -45.72%
2021 -33.26%
2020 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.01 -13.08%
AU
$138.18 473.58%
US
$750.94 6.02%
CH